FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113971256> ?p ?o ?g. }

• W2113971256 endingPage "78" @default.
• W2113971256 startingPage "71" @default.
• W2113971256 abstract "Abstract Glioblastomas are highly aggressive primary brain tumors. Curative treatment by surgery and radiotherapy is generally impossible due to the presence of diffusely infiltrating tumor cells. Furthermore, the blood-brain barrier (BBB) in infiltrative tumor areas is largely intact, and this hampers chemotherapy as well. The occurrence of angiogenesis in these tumors makes these tumors attractive candidates for antiangiogenic therapies. Because antiangiogenic compounds have been shown to synergize with chemotherapeutic compounds in other tumor types, based on vessel normalization, there is a tendency toward such combination therapies for primary brain tumors also. However, vessel normalization in brain may result in restoration of the BBB with consequences for the efficacy of chemotherapeutic agents. In this study, we investigated this hypothesis. BALB/c nude mice with intracerebral xenografts of the human glioblastoma lines E98 or U87 were subjected to therapy with different dosages of vandetanib (an angiogenesis inhibitor), temozolomide (a DNA alkylating agent), or a combination (n &gt; 8 in each group). Vandetanib selectively inhibited angiogenic growth aspects of glioma and restored the BBB. It did not notably affect diffuse infiltrative growth and survival. Furthermore, vandetanib antagonized the effects of temozolomide presumably by restoration of the BBB and obstruction of chemodistribution to tumor cells. The tumor microenvironment is an extremely important determinant for the response to antiangiogenic therapy. Particularly in brain, antiangiogenic compounds may have adverse effects when combined with chemotherapy. Thus, use of such compounds in neuro-oncology should be reconsidered. [Mol Cancer Ther 2008;7(1):71–8]" @default.
• W2113971256 created "2016-06-24" @default.
• W2113971256 creator A5013281130 @default.
• W2113971256 creator A5019822912 @default.
• W2113971256 creator A5030947676 @default.
• W2113971256 creator A5050961926 @default.
• W2113971256 creator A5077895949 @default.
• W2113971256 creator A5079037442 @default.
• W2113971256 date "2008-01-01" @default.
• W2113971256 modified "2023-10-03" @default.
• W2113971256 title "Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization" @default.
• W2113971256 cites W1265988497 @default.
• W2113971256 cites W1567768016 @default.
• W2113971256 cites W1969328947 @default.
• W2113971256 cites W1969367931 @default.
• W2113971256 cites W1999966784 @default.
• W2113971256 cites W2004144303 @default.
• W2113971256 cites W2006202974 @default.
• W2113971256 cites W2023692811 @default.
• W2113971256 cites W2031376430 @default.
• W2113971256 cites W2046507292 @default.
• W2113971256 cites W2057149384 @default.
• W2113971256 cites W2067055586 @default.
• W2113971256 cites W2082572214 @default.
• W2113971256 cites W2096893939 @default.
• W2113971256 cites W2099087398 @default.
• W2113971256 cites W2104387616 @default.
• W2113971256 cites W2142412446 @default.
• W2113971256 cites W2147535764 @default.
• W2113971256 cites W2154451644 @default.
• W2113971256 cites W2157769714 @default.
• W2113971256 cites W72344367 @default.
• W2113971256 doi "https://doi.org/10.1158/1535-7163.mct-07-0552" @default.
• W2113971256 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18187807" @default.
• W2113971256 hasPublicationYear "2008" @default.
• W2113971256 type Work @default.
• W2113971256 sameAs 2113971256 @default.
• W2113971256 citedByCount "94" @default.
• W2113971256 countsByYear W21139712562012 @default.
• W2113971256 countsByYear W21139712562013 @default.
• W2113971256 countsByYear W21139712562014 @default.
• W2113971256 countsByYear W21139712562015 @default.
• W2113971256 countsByYear W21139712562016 @default.
• W2113971256 countsByYear W21139712562017 @default.
• W2113971256 countsByYear W21139712562018 @default.
• W2113971256 countsByYear W21139712562019 @default.
• W2113971256 countsByYear W21139712562020 @default.
• W2113971256 countsByYear W21139712562021 @default.
• W2113971256 countsByYear W21139712562022 @default.
• W2113971256 countsByYear W21139712562023 @default.
• W2113971256 crossrefType "journal-article" @default.
• W2113971256 hasAuthorship W2113971256A5013281130 @default.
• W2113971256 hasAuthorship W2113971256A5019822912 @default.
• W2113971256 hasAuthorship W2113971256A5030947676 @default.
• W2113971256 hasAuthorship W2113971256A5050961926 @default.
• W2113971256 hasAuthorship W2113971256A5077895949 @default.
• W2113971256 hasAuthorship W2113971256A5079037442 @default.
• W2113971256 hasBestOaLocation W21139712561 @default.
• W2113971256 hasConcept C126322002 @default.
• W2113971256 hasConcept C142724271 @default.
• W2113971256 hasConcept C143998085 @default.
• W2113971256 hasConcept C2776056115 @default.
• W2113971256 hasConcept C2776694085 @default.
• W2113971256 hasConcept C2777389519 @default.
• W2113971256 hasConcept C2778019345 @default.
• W2113971256 hasConcept C2778227246 @default.
• W2113971256 hasConcept C2778402981 @default.
• W2113971256 hasConcept C2778695046 @default.
• W2113971256 hasConcept C2779130545 @default.
• W2113971256 hasConcept C2780333294 @default.
• W2113971256 hasConcept C2780394083 @default.
• W2113971256 hasConcept C2781303535 @default.
• W2113971256 hasConcept C502942594 @default.
• W2113971256 hasConcept C509974204 @default.
• W2113971256 hasConcept C529278444 @default.
• W2113971256 hasConcept C71924100 @default.
• W2113971256 hasConcept C98274493 @default.
• W2113971256 hasConceptScore W2113971256C126322002 @default.
• W2113971256 hasConceptScore W2113971256C142724271 @default.
• W2113971256 hasConceptScore W2113971256C143998085 @default.
• W2113971256 hasConceptScore W2113971256C2776056115 @default.
• W2113971256 hasConceptScore W2113971256C2776694085 @default.
• W2113971256 hasConceptScore W2113971256C2777389519 @default.
• W2113971256 hasConceptScore W2113971256C2778019345 @default.
• W2113971256 hasConceptScore W2113971256C2778227246 @default.
• W2113971256 hasConceptScore W2113971256C2778402981 @default.
• W2113971256 hasConceptScore W2113971256C2778695046 @default.
• W2113971256 hasConceptScore W2113971256C2779130545 @default.
• W2113971256 hasConceptScore W2113971256C2780333294 @default.
• W2113971256 hasConceptScore W2113971256C2780394083 @default.
• W2113971256 hasConceptScore W2113971256C2781303535 @default.
• W2113971256 hasConceptScore W2113971256C502942594 @default.
• W2113971256 hasConceptScore W2113971256C509974204 @default.
• W2113971256 hasConceptScore W2113971256C529278444 @default.
• W2113971256 hasConceptScore W2113971256C71924100 @default.
• W2113971256 hasConceptScore W2113971256C98274493 @default.
• W2113971256 hasIssue "1" @default.
• W2113971256 hasLocation W21139712561 @default.

• next